Low T May Raise Death Risk
A study of 930 men with coronary heart disease (CHD) showed that those who had testosterone deficiency were at increased risk of death.
The overall prevalence of biochemical testosterone deficiency in the study population was 20.9% using a level of bioavailable testosterone levels below 2.6 nmol/L, 16.9% using a total testosterone level below 8.1 nmol/L, and 24% using both measures.
The investigators observed excess mortality in the androgen-deficient group compared with men with normal androgen levels (21% vs. 12%), according to a report in Heart (2010;96:1821-1825). Although the study could not determine whether low testosterone levels cause increased mortality or are merely markers of risk due to underlying disease, the investigators point out that serum testosterone level could prove to be a modifiable risk factor of atherosclerotic disease.
Testosterone replacement therapy has been shown to help correct testosterone deficiency and improve overall health and well-being in men. Testosterone therapy can help increase energy levels, boost libido, and improve bone density, among other benefits. Moreover, recent research has also shown that testosterone replacement therapy can help improve cardiovascular health and lower the risk of heart disease in men with low testosterone levels.
In conclusion, testosterone replacement therapy may not only improve quality of life, but also help save your life. If you have CHD and believe you may have a testosterone deficiency, it is important to consult with your healthcare provider to determine if testosterone therapy is right for you. With appropriate testosterone replacement therapy, you can help lower your risk of death and improve your overall health and well-being.